# ARCH Venture Partners' Biotech Investments: 104 Startups in Its Portfolio (2026) > The 104 Biotech startups ARCH Venture Partners has backed, by stage: $15B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/arch-venture-partners-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series A 30 - [Erasca](https://millionrounds.com/company/erasca) - [Dispatch Bio](https://millionrounds.com/company/dispatch-bio) - [Tome Biosciences](https://millionrounds.com/company/tome-biosciences) - [Verve Therapeutics](https://millionrounds.com/company/verve-therapeutics) - [Treeline Biosciences](https://millionrounds.com/company/treeline-biosciences) - [Tenvie Therapeutics](https://millionrounds.com/company/tenvie-therapeutics) - [Bitterroot Bio](https://millionrounds.com/company/bitterroot-bio) - [Paratus Sciences](https://millionrounds.com/company/paratus-sciences) - [Codiak Biosciences](https://millionrounds.com/company/codiak-biosciences) - [Rhygaze](https://millionrounds.com/company/rhygaze) - [Epirium Bio](https://millionrounds.com/company/epirium-bio) - [Pheast Therapeutics](https://millionrounds.com/company/pheast-therapeutics) - [Areteia Therapeutics](https://millionrounds.com/company/areteia-therapeutics) - [Akamis Bio](https://millionrounds.com/company/akamis-bio) - [Locana](https://millionrounds.com/company/locana) - [Magnet Biomedicine](https://millionrounds.com/company/magnet-biomedicine) - [ImmuneID](https://millionrounds.com/company/immuneid) - [Moleculent](https://millionrounds.com/company/moleculent) - [*BT* BackThorn Therapeutics](https://millionrounds.com/company/backthorn-therapeutics) - [Advanced Medicine Partners](https://millionrounds.com/company/advanced-medicine-partners) - [Volastra Therapeutics](https://millionrounds.com/company/volastra-therapeutics) - [*P* PhaseRx](https://millionrounds.com/company/phaserx) - [Countable Labs](https://millionrounds.com/company/countable-labs) - [Ramona](https://millionrounds.com/company/ramona) +6 more ## Series B 29 - [*G* Grail](https://millionrounds.com/company/grail) - [Gossamer Bio](https://millionrounds.com/company/gossamer-bio) - [Denali Therapeutics](https://millionrounds.com/company/denali-therapeutics) - [Beam Therapeutics](https://millionrounds.com/company/beam-therapeutics) - [Mirador Therapeutics](https://millionrounds.com/company/mirador-therapeutics) - [*CT* City Therapeutics](https://millionrounds.com/company/city-therapeutics) - [CREATE Medicines](https://millionrounds.com/company/create-medicines) - [Hua Medicine](https://millionrounds.com/company/hua-medicine) - [JW Therapeutics](https://millionrounds.com/company/jw-therapeutics) - [Semma Therapeutics](https://millionrounds.com/company/semma-therapeutics) - [AIRNA](https://millionrounds.com/company/airna) - [Homology Medicines](https://millionrounds.com/company/homology-medicines) - [Chroma Medicine](https://millionrounds.com/company/chroma-medicine) - [Nohla Therapeutics](https://millionrounds.com/company/nohla-therapeutics) - [Syros Pharmaceuticals](https://millionrounds.com/company/syros-pharmaceuticals) - [SonoThera](https://millionrounds.com/company/sonothera) - [Singleron Biotechnologies](https://millionrounds.com/company/singleron-biotechnologies) - [BlackThorn Therapeutics](https://millionrounds.com/company/blackthorn-therapeutics) - [*O* ONI](https://millionrounds.com/company/oni) - [Lycera](https://millionrounds.com/company/lycera) - [ROME Therapeutics](https://millionrounds.com/company/rome-therapeutics) - [*KT* Karuna Therapeutics](https://millionrounds.com/company/karuna-therapeutics) - [Gate Bioscience](https://millionrounds.com/company/gate-bioscience) - [*JB* Just Biotherapeutics](https://millionrounds.com/company/just-biotherapeutics) +5 more ## Stage not reported 22 - [EQRx](https://millionrounds.com/company/eqrx) - [Rapport Therapeutics](https://millionrounds.com/company/rapport-therapeutics) - [bluebird bio](https://millionrounds.com/company/bluebird-bio) - [Vir Biotechnology](https://millionrounds.com/company/vir-biotechnology) - [BIND Therapeutics](https://millionrounds.com/company/bind-therapeutics) - [Lyell Immunopharma](https://millionrounds.com/company/lyell-immunopharma) - [*N* NeurogesX](https://millionrounds.com/company/neurogesx) - [Sana Biotechnology](https://millionrounds.com/company/sana-biotechnology) - [Remix Therapeutics](https://millionrounds.com/company/remix-therapeutics) - [*TP* Trubion Pharmaceuticals](https://millionrounds.com/company/trubion-pharmaceuticals) - [Glympse Bio](https://millionrounds.com/company/glympse-bio) - [*SB* Sienna Biopharmaceuticals](https://millionrounds.com/company/sienna-biopharmaceuticals) - [Lightcast](https://millionrounds.com/company/lightcast) - [Magnolia NeuroSciences](https://millionrounds.com/company/magnolia-neurosciences) - [*RT* Rodeo Therapeutics](https://millionrounds.com/company/rodeo-therapeutics) - [LunaPBC](https://millionrounds.com/company/lunapbc) - [Cero Therapeutics](https://millionrounds.com/company/cero-therapeutics) - [Excision BioTherapeutics](https://millionrounds.com/company/excision-biotherapeutics) - [Prime Medicine](https://millionrounds.com/company/prime-medicine) - [*OC* Oncofactor Corporation](https://millionrounds.com/company/oncofactor-corporation) - [Neumora Therapeutics](https://millionrounds.com/company/neumora-therapeutics) - [Sonoma Biotherapeutics](https://millionrounds.com/company/sonoma-biotherapeutics) ## Series C and later 21 - [ArsenalBio](https://millionrounds.com/company/arsenalbio) - [Encoded Therapeutics](https://millionrounds.com/company/encoded-therapeutics) - [*E* eGenesis](https://millionrounds.com/company/egenesis) - [bit.bio](https://millionrounds.com/company/bit-bio) - [LifeMine Therapeutics](https://millionrounds.com/company/lifemine-therapeutics) - [Dewpoint Therapeutics](https://millionrounds.com/company/dewpoint-therapeutics) - [Vividion Therapeutics](https://millionrounds.com/company/vividion-therapeutics) - [Metacrine](https://millionrounds.com/company/metacrine) - [908 Devices](https://millionrounds.com/company/908-devices) - [Nutcracker Therapeutics](https://millionrounds.com/company/nutcracker-therapeutics) - [KSQ Therapeutics](https://millionrounds.com/company/ksq-therapeutics) - [Carrick Therapeutics](https://millionrounds.com/company/carrick-therapeutics) - [*BB* Brii Biosciences](https://millionrounds.com/company/brii-biosciences) - [Boundless Bio](https://millionrounds.com/company/boundless-bio) - [Aspen Neuroscience](https://millionrounds.com/company/aspen-neuroscience) - [Integrated Diagnostics](https://millionrounds.com/company/integrated-diagnostics) - [Faraday Pharmaceuticals](https://millionrounds.com/company/faraday-pharmaceuticals) - [Quanterix](https://millionrounds.com/company/quanterix) - [Vizgen](https://millionrounds.com/company/vizgen) - [OncoResponse](https://millionrounds.com/company/oncoresponse) - [Boreal Genomics](https://millionrounds.com/company/boreal-genomics) ## Pre-seed and seed 2 - [*UB* UltraDx Bio](https://millionrounds.com/company/ultradx-bio) - [Nebula Genomics](https://millionrounds.com/company/nebula-genomics) ## Segment by segment ### Series A 30 startups · $2.9B raised - [**Erasca**](https://millionrounds.com/company/erasca) Erasca is a developer of oncology drugs intended to provide precision oncology options. United States $739M - [**Dispatch Bio**](https://millionrounds.com/company/dispatch-bio) Dispatch Bio is a biotechnology company founded in 2022, focused on developing a universal treatment for solid tumors. United States $216M - [**Tome Biosciences**](https://millionrounds.com/company/tome-biosciences) Tome Biosciences is a biotechnology company based in Watertown, MA, focused on advancing programmable genomic integration (PGI) to United States $213M - [**Verve Therapeutics**](https://millionrounds.com/company/verve-therapeutics) Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease. United States $202M - [**Treeline Biosciences**](https://millionrounds.com/company/treeline-biosciences) Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions. United States $200M - [**Tenvie Therapeutics**](https://millionrounds.com/company/tenvie-therapeutics) Tenvie Therapeutics, Inc. United States $200M - [**Bitterroot Bio**](https://millionrounds.com/company/bitterroot-bio) Bitterroot Bio, Inc. United States $145M - [**Paratus Sciences**](https://millionrounds.com/company/paratus-sciences) Paratus Sciences is a biotechnology startup founded in 2021, based in New York, NY, with a subsidiary in Singapore. United States $100M ### Series B 29 startups · $5.9B raised - [*G* **Grail**](https://millionrounds.com/company/grail) United States $1.6B - [**Gossamer Bio**](https://millionrounds.com/company/gossamer-bio) Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products. United States $567M - [**Denali Therapeutics**](https://millionrounds.com/company/denali-therapeutics) Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families. United States $547M - [**Beam Therapeutics**](https://millionrounds.com/company/beam-therapeutics) Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology. United States $322M - [**Mirador Therapeutics**](https://millionrounds.com/company/mirador-therapeutics) Mirador Therapeutics is a clinical-stage precision medicine company based in San Diego, California. United States $250M - [*CT* **City Therapeutics**](https://millionrounds.com/company/city-therapeutics) United States $235M - [**CREATE Medicines**](https://millionrounds.com/company/create-medicines) CREATE Medicines is a clinical-stage biotechnology company based in Cambridge, Massachusetts. United States $195M - [**Hua Medicine**](https://millionrounds.com/company/hua-medicine) Hua Medicine is a clinical-stage, innovative drug development company in China. China $192M ### Stage not reported 22 startups · $2.4B raised - [**EQRx**](https://millionrounds.com/company/eqrx) EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable. United States $1.2B - [**Rapport Therapeutics**](https://millionrounds.com/company/rapport-therapeutics) Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders. United States $250M - [**bluebird bio**](https://millionrounds.com/company/bluebird-bio) bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. United States $151M - [**Vir Biotechnology**](https://millionrounds.com/company/vir-biotechnology) Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions. United States $150M - [**BIND Therapeutics**](https://millionrounds.com/company/bind-therapeutics) BIND Therapeutics is a biotechnology company incorporated in 2006; Pfizer acquired substantially all of its assets in 2016. United States $138M - [**Lyell Immunopharma**](https://millionrounds.com/company/lyell-immunopharma) Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer. United States $100M - [*N* **NeurogesX**](https://millionrounds.com/company/neurogesx) NeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain. United States $92M - [**Sana Biotechnology**](https://millionrounds.com/company/sana-biotechnology) Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients. United States $69M ### Series C and later 21 startups · $3.6B raised - [**ArsenalBio**](https://millionrounds.com/company/arsenalbio) ArsenalBio is a programmable cell therapy company that offers advanced CAR T-cell therapies for solid tumors. United States $410M - [**Encoded Therapeutics**](https://millionrounds.com/company/encoded-therapeutics) Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies. United States $379M - [*E* **eGenesis**](https://millionrounds.com/company/egenesis) United States $329M - [**bit.bio**](https://millionrounds.com/company/bit-bio) bit.bio is a synthetic biology and cell programming company based in Cambridge, United Kingdom. United Kingdom $264M - [**LifeMine Therapeutics**](https://millionrounds.com/company/lifemine-therapeutics) LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines. United States $230M - [**Dewpoint Therapeutics**](https://millionrounds.com/company/dewpoint-therapeutics) Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. United States $196M - [**Vividion Therapeutics**](https://millionrounds.com/company/vividion-therapeutics) We are bringing more disease-causing targets within the reach of small molecule therapeutics to transform care for patients with d United States $185M - [**Metacrine**](https://millionrounds.com/company/metacrine) Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs. United States $173M ### Pre-seed and seed 2 startups · $18M raised - [*UB* **UltraDx Bio**](https://millionrounds.com/company/ultradx-bio) UltraDx Bio is a biotechnology company that specializes in single-molecule digital high-sensitivity protein detection technology. China $14M - [**Nebula Genomics**](https://millionrounds.com/company/nebula-genomics) Nebula Genomics is a personal genomics company based in San Francisco, California, founded in 2016 by Dr. United States $4.3M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names ARCH Venture Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **ARCH Venture Partners' Pharma portfolio** 15 startups · $6.5B](https://millionrounds.com/portfolio-maps/arch-venture-partners-pharma-portfolio)[Portfolio map **ARCH Venture Partners portfolio map** 143 startups · $36B](https://millionrounds.com/portfolio-maps/arch-venture-partners-portfolio-map)[Co-investors **Who invests with ARCH Venture Partners** 132 co-investors](https://millionrounds.com/portfolio-maps/arch-venture-partners-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio) ## Raising from investors like ARCH Venture Partners? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)